Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Recurrent Ovarian Cancer Paradigm Continues to Evolve

Caroline Seymour
Published: Wednesday, Aug 21, 2019

Madeleine B. Courtney Brooks, MD, MPH, a gynecologic oncologist at the University of Pittsburgh Medical Center

Madeleine B. Courtney Brooks, MD, MPH

Chemotherapy is the foundation of treatment for patients with recurrent ovarian cancer, but according to Madeleine B. Courtney Brooks, MD, MPH, conversations regarding the potential for secondary debulking and use of bevacizumab (Avastin) may also be warranted.  
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication